Could Johnson & Johnson Vaccine Come Back on the Market?
Federal health officials meet Friday to discuss the pause of using the J&J Janssen coronavirus vaccine. The pause was because of extremely rare blood clots in some patients. Could the vaccine return to market with the right disclaimer or message of caution? Peter Pitts, former FDA associate commissioner, explains.